Man Group PLC Concert Pharmaceuticals, Inc. Transaction History

Man Group PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $116,177 - $156,330	26,769 New	26,769 $156,000
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $83,788 - $116,459	-22,225 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $232,254 - $624,602	-47,789 Reduced 68.26%	22,225 $111,000
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $19,908 - $26,964	-2,100 Reduced 2.91%	70,014 $885,000
Q3 2020 Nov 16, 2020	SELL	$8.67 - $10.82 $6,936 - $8,656	-800 Reduced 1.1%	72,114 $708,000

Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $90,378 - $133,482	-11,587 Reduced 13.71%	72,914 $725,000
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $18,615 - $40,749	-3,113 Reduced 3.55%	84,501 $747,000
Q4 2019 Feb 18, 2020	SELL	$5.71 - $9.22 $2,855 - $4,610	-500 Reduced 0.57%	87,614 $808,000
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $429,357 - $901,797	-73,020 Reduced 45.32%	88,114 $518,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $34,928 - $48,544	-3,700 Reduced 2.24%	161,134 $1.93 Million
Q1 2019 May 15, 2019	SELL	$12.07 - $17.54 $20,410 - $29,660	-1,691 Reduced 1.02%	164,834 $1.99 Million
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $1.56 Million - $2.24 Million	-138,230 Reduced 45.36%	166,525 $2.09 Million
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $279,476 - $389,784	-21,800 Reduced 6.68%	304,755 $4.52 Million
Q2 2018 Aug 14, 2018	SELL	$16.83 - $21.66 $320,948 - $413,056	-19,070 Reduced 5.52%	326,555 $5.5 Million
Q1 2018 May 15, 2018	BUY	$19.24 - $28.03 $6.65 Million - $9.69 Million	345,625 New	345,625 $7.92 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.